Active Surveillance Tied to Higher Long-Term Cervical Cancer Risk
By Lori Solomon HealthDay Reporter
THURSDAY, Nov. 30, 2023 -- Undergoing active surveillance for cervical intraepithelial neoplasia grade 2 (CIN2) is associated with higher long-term risk for cervical cancer compared with that seen for women receiving immediate treatment, according to a study published online Nov. 29 in The BMJ.
Kathrine Dyhr Lycke, from Aarhus University in Denmark, and colleagues assessed the long-term risk for cervical cancer in women with CIN2 who were untreated (undergoing active surveillance) or had undergone immediate treatment with large loop excision of the transformation zone (LLETZ). The analysis included 27,524 women with diagnosed CIN2 (from 1998 to 2020) at ages 18 to 40 years.
The researchers found that during follow-up, 104 cases of cervical cancer were identified: 56 (54 percent) in the active surveillance group and 48 (46 percent) in the LLETZ group. During an active surveillance period of two years, the cumulative risk for cervical cancer was similar between the two groups. At more than two years of active surveillance, the risk increased to 2.65 percent after 20 years compared with remining stable (0.76 percent) in the LLETZ group.
"Undergoing active surveillance for CIN2, thereby leaving the lesion untreated, was associated with increased long-term risk of cervical cancer compared with immediate LLETZ," the authors write. "These findings show the importance of continued follow-up of women having active surveillance."
Several authors disclosed ties to AstraZeneca and Roche Denmark.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Vaginal Cancer Incidence Increasing Globally
WEDNESDAY, July 3, 2024 -- The incidence of vaginal cancer is increasing globally, according to a study published online June 25 in BJOG: An International Journal of Obstetrics...
Survival Improves With Open Hysterectomy for Cervical Cancer
FRIDAY, June 28, 2024 -- For patients with early-stage cervical cancer, disease-free and overall survival are lower for patients undergoing minimally invasive versus open radical...
Past-Year Pap Testing Rates Were Lower in 2022 Than 2019
FRIDAY, June 14, 2024 -- Past-year Papanicolaou testing rates were lower in 2022 than in 2019, overall, and lower rates were seen in rural versus urban women, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.